LONDON, April 25, 2025 /PRNewswire/ — On 22nd May 2025, the free-to-attend Employee Engagement Summit marks its 10th anniversary with a move to the prestigious Evolution London, allowing 2,000 attendees to join us across 7 content stages. The summit remains dedicated to exploring the key theme: Redefining How Organisations Connect With Their Employees, bringing together the world’s most influential brands and industry leaders for a transformative day.

A Decade of Innovation: The Premier Event for Engagement Professionals

This year’s event promises an unmatched experience, featuring exclusive case studies, dynamic panel discussions, and executive interviews with senior voices from HSBC, Formula E, NHS Scotland, Nationwide, PepsiCo, L’Oréal, Oxfam, Channel 4, Jaguar Land Rover, De Beers Group, and more.

A World-Class Expo: Connecting with 100 Employee Software Leaders

Our Event Partners help employee engagement leaders drive tangible change in their organisations. They are an ecosystem of hand-selected vendors, each with a different area of expertise, from employee recognition to culture building to internal communications. The Summit features a dynamic expo showcasing over 100 of the industry’s leading employee engagement providers as sponsors and exhibitors. Attendees can connect with the solutions they need to drive real impact, and Event Partners can meet face-to-face with senior decision-makers looking to invest in employee experience.

Agenda Highlights:

Main Stage Keynotes & Case Studies: A stage dedicated to those in C-Suite positions. Insights from the British Army, Virgin Group, and Formula E on aligning people strategies and future-proofing the workforce.

Organisational Culture Deep Dives: Lloyds Banking Group, L’Oréal, and Four Seasons Hotels and Resorts share how they’re building feedback-driven cultures and measuring engagement impact.

Wellbeing & Inclusion: Ocado Group, WWF, and Channel 4 unveil holistic wellbeing and inclusion strategies that create meaningful connections.

Internal Communications Masterclasses: King’s College Hospital NHS Foundation Trust, Tesco, and Dr. Martens showcase best practices for remote, hybrid, and AI-enhanced communications.

Talent, Recruitment & Retention: Jaguar Land Rover, Fortnum & Mason, and British Airways discuss talent development, impactful onboarding, and technology adoption for a connected workforce.

Employee Benefits, Reward & Recognition: Diageo, PepsiCo, Tom Ford, and G4S reveal how personalised rewards and recognition drive engagement and loyalty.

Interactive Formats for Maximum Engagement

Case Studies: Real-world success stories from global brands, packed with actionable takeaways.

Panel Discussions: Debates on the future of work, digital transformation, hybrid collaboration, and more.

Executive Interviews: Exclusive insights from Chief People Officers at the forefront of employee experience.

Why Attend?

Network with 2,000 senior employee engagement leaders

Soak up world-class insights across 7 content stages.

Discover the latest technologies and solutions

Benchmark your strategies against the world’s best and return with practical tools to redefine engagement in your organisation.

Join Us

Don’t miss your chance to be part of the UK’s most influential employee engagement event of the year.

For HR leaders, secure your free place and redefine how your organisation connects with employees on 22nd May 2025: https://hubs.ly/Q03hBl560

For sponsorship enquiries, please email us at commercial@ebm.uk 

For media enquiries, interviews, or to request a press pass, please contact us here: enquiries@ebm.uk

#EmployeeEngagementSummit

About the Summit:
Celebrating its 10th year, the Employee Engagement Summit is the annual gathering for HR, internal communications, and employee engagement professionals. This year’s summit at Evolution London features world-class speakers, actionable insights, and unparalleled networking opportunities, all focused on redefining how organisations connect with their people.

View original content:https://www.prnewswire.co.uk/news-releases/employee-engagement-summit-2025-redefining-how-organisations-connect-with-their-employees-302438221.html

VADUZ, Liechtenstein, April 25, 2025 /PRNewswire/ — The depository receipt holders of Implantica AG, reg. no. FL-0002.629.889-3, are hereby invited to attend the annual general meeting to be held on Thursday, May 15, 2025, at 14:00 at Hotel Kommod, Industriering 14, 9491 Ruggell, Liechtenstein.

Right to participate and notice

Anyone wishing to attend the annual general meeting must:

be entered as depository receipt holder in the Swedish Depository Receipt (“SDR”) register kept by the Swedish central securities depository Euroclear Sweden on Wednesday, April 30, 2025, andnotify the company of their intention to attend no later than May 7, 2025, by email to investorrelations@implantica.com or by post to Implantica AG, Annual General Meeting, Aeulestrasse 45, 9490 Vaduz, Liechtenstein

When giving notification to attend, please specify the SDR holder’s name, personal identity or company registration number, address, telephone number and the number of any representative (no more than two).

in lieu of physical participation, votes may be cast by the SDR holder no later than Wednesday, May 7, 2025, in accordance with the instructions on the Postal Voting Form, see appendix 1, so that the voting form is received by Pareto Securities AB (the “Custodian”) no later than that day. The Custodian will forward the votes for representation to the local independent proxy, Mr. Philipp Wanger, Attorney-at-law.

If SDR holders are represented by a proxy, a written and dated power of attorney signed by the SDR holder must be issued to the proxy. The power of attorney must not be older than one year, unless a longer validity term (maximum five years) has been stipulated. Anyone representing a legal entity must present a copy of the registration certificate or other document demonstrating the signatory’s authority to sign for the legal entity. In order to facilitate registration at the annual general meeting, the power of attorney as well as the registration certificate and other authorization documents should be received by the company at the above address by May 7, 2025, at the latest.

Holders of depository receipts who hold their receipts through nominees (Sw. förvaltare), such as a bank, must request a temporary registration of the voting rights in their own name in the share register kept by Euroclear Sweden (so called voting right registration) in order to be able to participate at the annual general meeting. Holders of depository receipts who want to obtain such registration must contact the nominee regarding this in advance of April 30, 2025.

Proposed agenda

Opening of the meeting and appointment of the Chair of the meetingPreparation and approval of the voting listApproval of the agendaAppointment of one or two persons to approve the minutesDetermination of whether the meeting has been duly convenedAddress by the CEO and CFOPresentation of the annual report, the statutory annual financial statements, the consolidated financial statements and auditor’s reportsResolution and adoption of the statutory financial statements and the consolidated financial statements of Implantica AG, acknowledging the reports of the auditorsResolution on the net result in accordance with the adopted balance sheetResolution on discharge of the Board of Directors, Executive Management and the AuditorsResolution on approval of remuneration of the Board of Directors and Executive ManagementElection of the Board of Directors and the Chairman and Vice-Chairman of the Board of Directors Election of the Chairman of the Board of DirectorsElection of the Vice-Chairman of the Board of DirectorsElection of the members of the Board of DirectorsElection of the Chairman and the member of the Nomination and Remuneration CommitteeElection of the independent proxyElection of the auditorsResolution on amendment of Article 4a para. 1 of the Articles of AssociationResolution on amendment of Article 4 para. 5 of the Articles of AssociationClosing of the meeting

Resolution proposals and Elections

The following agenda items are scheduled for the Annual General Meeting (“AGM”):

8. Resolution and adoption of the statutory financial statements and the consolidated financial statements of Implantica AG

Proposal of the Board of Directors:

Approval of the annual report 2024 consisting of the statutory financial statements and the consolidated financial statements of Implantica AG, acknowledging the reports of the auditors.

9. Resolution on the net result in accordance with the adopted balance sheet

Proposal of the Board of Directors:
Carry forward of the net loss for the financial year 2024 in accordance with the adopted balance sheet and to no payment of dividend.

10. Resolution on discharge of the Board of Directors, Executive Management and the Auditors

Proposal of the Board of Directors:

Granting of discharge to the members of the Board of Directors for financial year 2024.Granting of discharge to the members of the Executive Management for financial year 2024.Granting of discharge to the Auditor for financial year 2024.

11. Resolution on approval of remuneration of the Board of Directors and Executive Management

Proposal of the Board of Directors:

Approve the total remuneration of the Board of Directors of TEUR 106 for financial year 2024. The total remuneration includes fixed compensation, pension contributions and a long-term share-based incentive plan.Approve the total remuneration of the Executive Management of TEUR 821 for financial year 2024. The total remuneration includes fixed compensation, pension contributions and a long-term share-based incentive plan. Executive Management is made up of the Chief Executive Officer, the Chief Financial Officer, the Chief Strategy Officer and the Chief Corporate Affairs Officer.

12. Election of the Board of Directors and the Chairman and Vice-Chairman of the Board of Directors

The Board of Directors of the company currently consists of four ordinary members. It is proposed to re-elect all current board members for the period until the end of the next annual general meeting including the re-election of Liselott Kilaas as Chairman and Johan Bojs as Vice-Chairman.

Proposal of the Board of Directors:

Re-election of Liselott Kilaas as member and Chairman of the Board of Directors for a term of office until completion of the next Annual General Meeting of shareholders.Re-election of Johan Bojs as member and Vice-Chairman of the Board of Directors for a term of office until completion of the next Annual General Meeting of shareholders.Re-election of Tomas Puusepp as member of the Board of Directors for a term of office until completion of the next Annual General Meeting of shareholders.Re-election of Stephan Siegenthaler as member of the Board of Directors for a term of office until completion of the next Annual General Meeting of shareholders.

13. Election of members and Chairman of the Nomination and Remuneration Committee

Proposal of the Board of Directors: 

Re-election of Johan Bojs as Chairman of the Nomination and Remuneration Committee for a term of office until completion of the next Annual General Meeting of shareholders.Election of Tomas Puusepp as member of the Nomination and Remuneration Committee for a term of office until completion of the next Annual General Meeting of shareholders.

14. Election of the independent proxy

Proposal of the Board of Directors: 

Re-election of Philipp Wanger, Attorney-at-law, Neugasse 17, 9490 Vaduz, Liechtenstein as independent proxy until the next annual general meeting of shareholders.

15. Election of the auditors

Proposal of the Board of Directors:

Re-election of KPMG (Liechtenstein) AG, Aeulestrasse 2, 9490 Vaduz, Liechtenstein as auditor for the financial year 2025.

16. Resolution on amendment of Article 4a para. 1 of the Articles of Association

Resolve on an authorization for the board of directors to, with or without deviation from the shareholders’ preferential rights, resolve on new share issues. The objective of the authorization is to provide the board of directors with flexibility in its work to ensure that the company can procure capital for the financing of the operations in an appropriate manner, to enable business or company acquisitions and to enable a broadening of the company’s shareholder base.

Proposal of the Board of Directors:
Art. 4a para. 1: The Board of Directors is authorized to increase the share capital, at any time until May 14, 2030, by a maximum amount of CHF 69’461’536 by issuing a maximum of 34’730’768 fully paid up registered ordinary shares (Class A) with a par value of CHF 2 each. An increase of the share capital in partial amounts shall be permissible.

Art. 4a Abschnitt 1: Der Verwaltungsrat ist ermächtigt, jederzeit bis zum 14. Mai 2030 das Aktienkapital im Maximalbetrag von CHF 69’461’536 durch Ausgabe von höchstens 34’730’768 voll zu liberierenden auf den Namen lautende Aktien (Class A) mit einem Nennwert von je CHF 2 zu erhöhen. Erhöhungen in Teilbeträgen sind gestattet.

17. Resolution on amendment of Article 4 para. 5 of the Articles of Association

Resolve on an authorization for the board of directors to, with or without deviation from the shareholders’ preferential rights, resolve on new share issues for the exercise of contingent capital comprising conversion rights or options in relation with convertible debt instruments. The objective of the authorization is to provide the board of directors with flexibility in its work to ensure that the company can procure capital for the financing of the operations in an appropriate manner, to enable business or company acquisitions and to enable a broadening of the company’s shareholder base. Furthermore, to resolve on adding the sentence, “An increase of the share capital in partial amounts shall be permissible,” to this Article 4 para. 5.

Proposal of the Board of Directors:
Art. 4 para. 5: The share capital may be increased by a maximum of CHF 69’461’536 through the issuance of a maximum of 34’730’768 fully paid up registered ordinary shares (Class A) with a par value of CHF 2 each by means of the exercise of conversion rights or options in relation with convertible debt instruments, loans and similar forms of financing of the Company or of a subsidiary company. The conditions for the granting of the option rights and conversion rights shall be determined by the Board of Directors. The Board of Directors is authorized to restrict or exclude shareholders’ advance subscription rights if the convertible debt instruments, loans and similar forms of financing are used, (i) in connection with the financing and refinancing of the business of the Company or its subsidiaries or (ii) in connection with the financing and refinancing of the takeover of companies, parts of companies, interests or co-operations or strategic partnerships. To the extent shareholders’ advance subscription rights are excluded, the exercise period for conversion and option rights granted shall not exceed 5 years and the conversion or exercise price for the new shares to be issued shall at least correspond to the market conditions at the time of the issue of the relevant debt or loan instrument. An increase of the share capital in partial amounts shall be permissible.

Art. 4 Abschnitt 5: Das Aktienkapital kann sich durch Ausgabe von maximal 34’730’768 voll zu liberierenden Namenaktien (Class A) im Nennwert von je CHF 2 um maximal CHF 69’461’536 erhöhen, infolge der Ausübung von Wandel- oder Optionsrechte, welche in Zusammenhang mit Wandelschuldinstrumenten, Wandeldarlehen und ähnlichen Finanzierungsformen der Gesellschaft oder einer ihrer Tochtergesellschaften eingeräumt worden sind. Die Ausgabebedingungen für die Options- und Wandelrechte werden durch den Verwaltungsrat festgelegt. Der Verwaltungsrat ist ermächtigt, das Vorwegzeichnungsrecht der Aktionäre aufzuheben oder einzuschränken, sofern die Wandelschuldinstrumente, Wandeldarlehen und ähnliche Finanzierungsformen (i) im Zusammenhang mit der Finanzierung und Refinanzierung der Gesellschaft oder ihrer Tochtergesellschaften, oder (ii) im Zusammenhang mit der Finanzierung und Refinanzierung der Übernahme von Unternehmen, Unternehmensteilen, Beteiligungen oder Kooperationen und strategischen Partnerschaften verwendet werden. Soweit das Vorwegzeichnungsrecht ausgeschlossen ist, ist die Ausübungsfrist auf höchstens fünf Jahre und der Ausgabepreis für die neuen Aktien mindestens zu den Marktbedingungen zum Zeitpunkt der Ausgabe des Schuldinstruments bzw. Darlehens anzusetzen. Erhöhungen in Teilbeträgen sind gestattet.

Number of shares and votes in the company

Implantica AG has two classes of shares, class A and class B. The class A shares are listed on the Nasdaq First North Premier Growth Market, through Swedish Depository Receipts (“SDRs”). One SDR represents one class A share in Implantica AG. Each class A and class B share provide entitlement to one vote. The total number of class A shares in the company amounts to 58,211,537 shares with a nominal value of CHF 2.00 each (class A) and 1,125,000,000 class B shares with a nominal value of CHF 0.02 each (class B), therefore, the total number of votes in the company amounts to 1,183,211,537 votes. At the date of this notice, there are 14,321 SDRs representing treasury class A shares, which cannot be represented at the annual general meeting.

Information at the meeting

The board of directors and the CEO shall, if any SDR holder so requests and the board of directors believes that it can be done without material harm to the company, provide information regarding circumstances that may affect the assessment of an item on the agenda, circumstances which may affect the assessment of the company’s or subsidiaries’ financial position and circumstances that may affect the company’s relation to other companies within the group. SDR holders who want to submit questions in advance may do so in writing by way of e-mail at investorrelations@implantica.com. 

Documents

Complete proposals and statements, including the auditor’s statement, as well as accounting documents and audit report for 2024, will be available at the company’s offices on Aeulestrasse 45, 9490 Vaduz, Liechtenstein and on the company’s website, www.implantica.com, no later than three weeks before the general meeting.

Minutes

The minutes of the annual general meeting will be available for review from the evening of June 13, 2025, at the latest at the company’s headquarters, Aeulestrasse 45, 9490 Vaduz, Liechtenstein and on the company’s website www.implantica.com.

Processing of personal data

For information on how your personal data is processed, see https://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf.

Implantica AG
The Board of Directors
April 25, 2025

For further information, please contact:
Nicole Pehrsson, Chief Corporate Affairs Officer
Telephone (CH): +41 (0)79 335 09 49
nicole.pehrsson@implantica.com

Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm.

The company’s Certified Adviser is FNCA Sweden AB, info@fnca.se

The information was sent for publication, through the agency of the contact person set out above, on April 25, 2025, at 10:15 a.m. CEST.

About Implantica

Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica’s lead product, RefluxStop™, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energising platform designed to power remote controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit www.implantica.com for further information.

Newsroom
https://www.implantica.com/media/media-kit

Media Contact:
Implantica AG
Juanita Eberhart, VP Marketing & Advocacy
M: +1 925-381-4581
juanita.eberhart@implantica.com 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/implantica/r/notice-of-annual-general-meeting-of-implantica-ag,c4140327

The following files are available for download:

View original content:https://www.prnewswire.co.uk/news-releases/notice-of-annual-general-meeting-of-implantica-ag-302438228.html

LONDON, April 25, 2025 /PRNewswire/ — iFAST Global Bank (“iGB” or the “Bank”) is making new strides in UK banking with the launch of its unique Multi-Currency Current Account, an innovative solution that lets customers earn competitive interest rates on multiple currencies while enjoying rewards on everyday debit card spending.

With the iFAST Global Bank debit card powered by Visa, a global leader in digital payments, customers can spend seamlessly in the UK and around the world. The card’s unique numberless design, featuring no printed card number, CVV, or expiry date, provides an added layer of security, with all sensitive details securely managed within the mobile app.

“At iFAST Global Bank, our commitment to IT innovation drives us to deliver a seamless, fully digital onboarding experience through both our app and website. Complementing this is our dedicated digital customer service team, which is committed to offering prompt and efficient support, wherever our customers may be in the world. To make this possible, we need a partner with proven global reach and deep expertise. In Visa, we have found a partner supporting us in developing a secure, customer-focused product,” said Inayat Kashif, Acting CEO, Executive Director and Chief Technology Officer of iFAST Global Bank. 

Mathieu Altwegg, Senior Vice President, Products and Solutions, Europe at Visa, also commented: “At Visa, we’re pleased to support partners like iFAST Global Bank as they introduce their Multi-Currency Current Account to the UK market. This collaboration reflects our shared goal of enhancing innovation and providing greater choice, access, and value to customers.”

With iFAST Global Bank’s unique Multi-Currency Current Account, UK customers are empowered to grow their money while maintaining full access to their funds. The account offers competitive interest rates, including 3.50% AER (variable) on GBP, 1.50% AER (variable) on EUR, and 2.80% AER (variable) on USD, with no maximum interest caps.

With the Visa-enabled debit card, customers can also enjoy 2% cashback on up to £2,000 of spending per month. The offer is valid for a limited time period, subject to applicable terms and conditions. Unlike traditional accounts, the iFAST Global Bank Multi-Currency Current Account simplifies banking by eliminating the need to transfer funds between savings and current accounts. Designed as a customer-first, all-in-one solution, it provides UK customers with simplicity, convenience, and flexibility.

Why This Account Stands Out

Unlimited High Interest: No minimum balance, no interest caps, maximising returns, on everyday balances backed by FSCS protection up to £85,000. Multi-Currency Convenience: Effortlessly save, spend, and send money abroad across multiple currencies with competitive exchange rates.Global Payment Security: A multi-currency numberless Visa-enabled debit card, accepted in over 200 countries. With no printed card number, CVV, or expiry date, it offers enhanced security, with all details securely stored and managed in the mobile app. Digital Customer Service: Get timely support via Live Chat and Live Call over the Internet, eliminating the need to dial a phone number, even when overseas. Available 7 days a week during office hours.

Headquartered in London, iFAST Global Bank is the global digital banking arm of Singapore-based iFAST Corporation. The Bank ensures the security of customer deposits, with protection of up to £85,000 under the FSCS scheme. Recognised for its excellence, the bank was recently named Moneyfacts Highly Commended App-Only Savings Provider of the Year 2025 and Commended for Best Customer Service. Demonstrating strong financial performance, iFAST Global Bank achieved profitability in 4Q2024 and surpassed S$1 billion in customer deposits as of end-December 2024, a significant milestone in its growth trajectory.

About iFAST Corporation & iFAST Global Bank

iFAST Corporation is a global digital banking and wealth management platform, with assets under administration of S$25.01 billion as at 31 December 2024. Established in 2000, it operates in Singapore, Hong Kong, Malaysia, China, and the UK. iFAST Global Bank is a fully licensed UK bank, offering multi-currency deposits, payment services, and remittance solutions. Regulated by the Prudential Regulation Authority (PRA) and Financial Conduct Authority (FCA), the Bank is a direct member of the Bank of England Faster Payment Scheme, Clearing House Automated Payment System (CHAPS) and SWIFT.

For more information, visit www.ifastgb.com

Media Contact:
Rachelle Au-Yeung | (+44) 7793 469015 | rachelle.auyeung@ifastgb.com / corpcomms@ifastfinancial.com

All brand names, logos and/or trademarks are the property of their respective owners, are used for identification purposes only, and do not necessarily imply product endorsement or affiliation with Visa.

View original content:https://www.prnewswire.co.uk/news-releases/ifast-global-bank-unveils-multi-currency-current-account-offering-high-interest-and-cashback-collaborating-with-visa-on-debit-card-302438231.html